IMRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Microsoft Corp in 2026
IMRX
Immuneering Corp
$5.70
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | IMRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $356.88M | N/A | IMRX |
| P/E Ratio | N/A | 23.21 | MSFT |
| EPS (TTM) | $N/A | $15.98 | MSFT |
| Revenue Growth | -1.0% | 0.2% | MSFT |
| Gross Margin | 34907.7% | 68.6% | IMRX |
Analyze IMRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or MSFT a better investment?
Comparing IMRX and MSFT: Immuneering Corp has a market cap of $356.88M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and MSFT?
IMRX (Immuneering Corp) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or MSFT?
MSFT has higher revenue growth at 0.2% vs -1.0% for IMRX.
Which company is more profitable: IMRX or MSFT?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 68.6% for MSFT.
Which is the larger company: IMRX or MSFT?
Immuneering Corp (IMRX) is larger with a market cap of $356.88M compared to N/A for MSFT.
Should I buy IMRX or MSFT in 2026?
Both IMRX and MSFT have investment merit. IMRX trades at $5.70 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and MSFT stock?
Key differences: Market Cap ($356.88M vs N/A), P/E Ratio (N/A vs 23.2x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (34907.7% vs 68.6%).